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Significance of Pathophysiology
Available treatment options for 
patients diagnosed with cancer 
include surgery, the administration 
of chemotherapeutic agents, 
radiation therapy, or a combination 
of these modalities. 
Chemotherapeutic agents utilized to 
treat cancer have a variety of 
potential side effects. One of the 
most common and well known side 
effects associated with the 
administration of chemotherapeutic 
agents is neutropenia. An estimated 
60,000 cancer patients require 
hospitalization each year due to 
chemotherapy induced neutropenia 
related to standard treatment 
regimens (Demshar, Vanek, & 
Mazanec, 2011). While the criteria 
defining neutropenia varies among 
institutions, neutropenia may 
typically be defined as an absolute 
neutrophil count (ANC) less than 
1500 cells per microliter with severe 
neutropenia defined as an ANC less 
than 500 cells per microliter (White 
& Ybarra, 2014). Neutropenia places 
oncology patients at an increased 
risk of contracting infections which 
may lead to a life threating 
complication known as sepsis. 
Sepsis is an extremely dangerous 
oncologic emergency requiring 
prompt medical treatment. Failure 
to recognize symptoms associated 
with sepsis in the neutropenic
patient and initiate appropriate 
medical treatment significantly 
increases the risk of patient 
mortality. White and Ybarra (2014) 
explain that the mortality risk in 
neutropenic patients with 
uncontrolled infection varies 
inversely with the severity of 
neutropenia; therefore, the morality 
risk in patients with an ANC less 
than 500 cells per microliter is 
markedly increased. The aim of this 
research project is to aid in further 
educating health care professionals 
on the pathophysiological process 
and implications for nursing 
practice associated with caring for 
patients with chemotherapy induced 
neutropenia and their increased risk 
for sepsis. 
• Neutrophils play an important role 
in the inflammatory response by 
releasing crucial regulatory 
cytokines, chemokines, and 
leukotrienes (Kovach & Standiford, 
2012).
• The administration of 
chemotherapeutic medications for 
the treatment of cancer carries 
profound effects on the function of 
the human immune system. 
Chemotherapeutic agents cause 
overwhelming destruction in bone 
marrow cells, particularly those that 
are in the reproductive phase, thus 
killing the cells and delaying the 
production and turnover of new, 
mature phagocytic cells (Held-
Warmkessel, 2011).
• The interval of time in which the 
patient’s cell count is at its lowest is 
referred to as the nadir period and 
during this time, the patient is at the 
greatest risk for infection (Held-
Warmkessel, 2011).
• Profound localized infections may 
spread systemically resulting in 
sepsis when the patient’s remaining 
mature neutrophils fail to 
appropriately phagocytize and 
annihilate invading microorganisms 
(Held-Warmkessel, 2011). 
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Neutropenia in patients receiving chemotherapeutic medications for the 
treatment of cancer can place patients at risk for potentially life threatening 
immune dysfunction. Prevention of infection, early detection of symptoms, and 
prompt intervention when concerns for infection arise are vital for positive 
patient outcomes. Vioral and Wentley (2015) noted that “nurses are integral in 
the prevention, identification, treatment, and management of these high 
mortality complications of immunosuppressive therapies” (p. 173). Ensuring 
that clinicians are well versed in their understanding of the pathophysiologic 
process and implications for nursing care further contribute to improvements in 
the quality of care received by the neutropenic patient.
Conclusion
Bone marrow suppression and subsequent neutropenia significantly increases a 
patient’s risk for bacterial infections that can rapidly progress to sepsis (Legrad et al., 
2012). Sepsis may be defined as “…a progressive, injurious, inflammatory response 
to overwhelming infection associated with tissue hypoperfusion and multiorgan 
dysfunction” (Kovach & Standiford, 2012, p. 321). Deficiency in the number of 
functioning neutrophils increases sepsis-mediated morbidity and mortality further 
emphasizing the consequences related to alterations in neutrophil response (Kovach 
& Standiford, 2012). Kovach and Standiford (2012) further argued that impaired 
neutrophil function leads to defective innate immunity culminating in septic patients. 
• Patients with neutropenia do not 
produce a sufficient number of 
mature neutrophils to mount an 
appropriate immune response 
against microorganism invasion 
(Vioral & Wentley, 2015). 
Therefore, neutropenic patients do 
not always present with classic 
signs and symptoms of infection.
• Often, the earliest and only 
response to an infection in the 
neutropenic patient is a fever 
(Bow, 2013). A single oral 
temperature greater than 101 
degrees Fahrenheit or a persistent 
(longer than one hour) oral 
temperature of 100.4 degrees 
Fahrenheit represents a fever in a 
patient with neutropenia (Vioral & 
Wentley, 2015). In patients with 
severe neutropenia, there may be 
substantial difficulty producing an 
immune response. Fever may not 
be exhibited and the patient may 
present with a temperature that is 
below normal, namely 
temperatures below 96.8 degrees 
Fahrenheit (Bow, 2013; O’Leary, 
2014). 
• The patient may also display 
alterations in vital signs, indicating 
progression towards sepsis and the 
presence of a systemic 
inflammatory response. Criteria 
concerning for the presence of 
systemic inflammatory response 
include elevated or subnormal 
temperatures, heart rate greater 
than ninety beats per min, or a 
respiratory rate greater than 
twenty breaths per minute (Bow, 
2013; O’Leary, 2014). Additionally, 
patients may rapidly develop 
symptoms of hypotension, altered 
mental status, and rigors 
(Demshar, et al., 2011). 
• Altered laboratory values such as a 
white blood cell (WBC) count less than 
4000 cells/mm3, less than ten percent 
band forms in the leukocyte differential 
count, and an ANC less than 1500 cells 
per microliter are also present (Bow, 
2013; O’Leary, 2014). 
• Patients with neutropenia often 
demonstrate infections involving the 
respiratory, gastrointestinal, 
genitourinary, and integumentary 
systems. Vioral and Wentley (2015) 
reported that assessment for abnormal 
breath sounds related to respiratory 
infections is critical as neutropenic 
patients with pneumonia do not always 
develop cough or sputum. Neutropenic 
patients presenting with complaints of 
abdominal pain and diarrhea should 
raise concerns for gastrointestinal 
infections such as Clostridium difficile 
(Vioral & Wentley, 2015). 
• The patient’s skin and mucosal 
membranes require examination for 
breaks in integrity or ulcerations 
accompanied by signs of edema, 
drainage, erythema, and tenderness 
always remembering that these signs 
and symptoms of infection may be 
muted or absent due to altered immune 
response related to the patient’s 
neutropenia (Vioral & Wentley, 2015).
Signs and Symptoms
• Patients should be educated on the 
necessity and timing of the 
administration of preventative 
vaccinations such as the influenza and 
pneumococcal vaccines. Vioral and 
Wentley (2015) recommended that 
patients complete vaccinations at 
least two weeks prior to the beginning 
of chemotherapeutic medications.
• Infection prevention measures that 
nurses should discuss with patients at 
high risk for neutropenia include the 
use of only electric razors for shaving, 
use of soft toothbrushes and 
importance of frequent oral care (at 
least three to four times daily), 
meticulous skin care (emphasizing 
the importance of good hand 
hygiene), proper central venous 
access device care, perianal cleansing 
after toileting, safe food handling and 
preparation, refraining from cleaning 
up animal excreta, avoiding contact 
with soil or plants, refraining from 
contact with people who have 
received recent live vaccines, and 
avoidance of anyone with colds, 
respiratory infections, and/or large 
crowds of people (Vioral & Wentley, 
2015). 
• Patients should be educated on the 
importance of monitoring their 
temperature multiple times daily and 
reporting any fever of 101 degrees 
Fahrenheit or persistent fevers 
greater than or equal to 100.4 degrees 
Fahrenheit to their healthcare 
provider. Education should also 
include signs and symptoms of 
infection such as redness, warmth, 
edema, and tenderness. Should 
preventative measures fail to provide 
adequate protection against infection, 
and concern for infection arises, it is 
important that nurses educate 
patients on when to seek medical 
assistance.
Underlying Pathophysiology
• In healthy individuals, the 
immune process is well regulated 
and the balance between 
counteracting forces maintains a 
localized inflammatory response 
to the area of initial insult (Laszlo, 
Trasy, Molnar, and Fazakas,  
2015).
• Important phagocytic cells of the 
innate immune system, including 
neutrophils, are produced from 
multipluripotent stem cells 
within the bone marrow 
throughout the lifespan (Held-
Warmkessel, 2011; Kovach & 
Standiford, 2012). 
• Neutrophils are released into the 
blood stream from the bone 
marrow as fully mature cells and 
circulate throughout the system 
where they adhere to the 
endothelial wall and move to the 
site of an infection (Kovach & 
Standiford, 2012; Vioral & 
Wentley, 2015). 
• Neutrophils are the first 
phagocytic cell to arrive at the site 
of an infection, function to fight 
against bacterial infections, guard 
against progression of infection, 
and produce common signs and 
symptoms of an infection 
including redness, swelling, and 
purulent drainage (Held-
Warmkessel, 2011; Vioral & 
Wentley, 2015). 
• Hawley, Loney, and Wiece (2011) 
stressed that “…nurses need to 
offer patients tangible education 
and take-home tools to reinforce 
what to do when potentially 
neutropenic to minimize delays in 
seeking medical attention and the 
risk of life-threating sepsis” (p. 
E53).
• When febrile neutropenia is 
suspected or confirmed, 
hospitalization is warranted and 
management requires rapid 
initiation of sepsis protocols to 
improve patient outcomes. 
• Nurses should anticipate that 
neutropenic patients with 
suspected sepsis will need to have 
lactate levels and blood cultures 
obtained (additional cultures such 
as urine, sputum, and stool may 
also be collected), aggressive fluid 
resuscitation will be initiated, and 
broad spectrum antibiotics will be 
administered within three hours of 
presentation to the department 
(O’Leary, 2014). 
• The removal of indwelling 
catheters should be requested and 
preformed when there is suspicion 
of catheter related bloodstream 
infections (Legrand et al., 2012). 
• Frequent monitoring of patient 
vital signs and continued physical 
assessments are important to 
assess patient response to 
treatment (Held-Warmkessel, 
2011). 
• When aggressive fluid 
resuscitation fails to restore 
hemodynamic stability and the 
need for the administration of 
vasopressors arises, nurses should 
advocate for patients to be 
transferred to intensive care units 
for closer monitoring. 
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